Interleukin-6 (IL-6), a pro-inflammatory cytokine, facilitates cancer development by activating the Janus kinase 2 (JAK2)–signal transducer and activator of transcription 3 (STAT3) pathways [12]. The gene discussed is JAK2; the disease is cancer.